Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)*
|
ADC Therapeutics SA (Name of Issuer) |
Common Shares, par value CHF 0.08 per share (Title of Class of Securities) |
H0036K147 (CUSIP Number) |
05/15/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | H0036K147 |
| 1 | Names of Reporting Persons
HPWH TH AG | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
SWITZERLAND
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
8,670,588.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
8.52 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
CO |
Comment for Type of Reporting Person: (1) Represents 8,670,588 shares held by HPWH TH AG. (2) The beneficial ownership percentage is calculated based on 101,811,051 ordinary shares of the Issuer issued and outstanding as of 5/13/25.
SCHEDULE 13G
|
| CUSIP No. | H0036K147 |
| 1 | Names of Reporting Persons
Dr. Hans-Peter Wild | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
SWITZERLAND
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
9,788,944.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
9.61 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: (1) Represents 9,788,944 shares held directly and indirectly by Dr. Hans-Peter Wild ("Dr. Wild"). The principal business of HPWH TH AG ("HPWH") is holding investment rights, directly or indirectly, in ADC Therapeutics SA. HP Wild Holding AG ("HPW Holding") is an intermediary holding company. Dr. Wild is the Chairman of HPWH and HPW Holding. Thomas Pfisterer ("Mr. Pfisterer") was a Board Member of HPWH and an investment manager but stepped down from this position. By reason of a stockholders' agreement by and among Mr. Pfisterer and HPW Holding and their joint indirect minority equity interest in HPWH via their joint ownership of HPWH MH AG ("MH"), which owns a 12.5% minority equity interest in HPWH, Mr. Pfisterer may have been deemed to have shared voting and investment power with respect to such shares held by HPWH, however, Mr. Pfisterer has disclaimed such power, has left all of such companies, and has transferred all of his direct or indirect interests in MH and HPWH to Dr. Wild. The business address of each of HPWH, HPW Holding and Dr. Wild is Neugasse 22, 6300 Zug, Switzerland. (2) The beneficial ownership percentage is calculated based on 101,811,051 ordinary shares of the Issuer issued and outstanding as of 5/13/25.
SCHEDULE 13G
|
| CUSIP No. | H0036K147 |
| 1 | Names of Reporting Persons
Thomas Pfisterer | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
SWITZERLAND
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
173,899.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
0.17 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: (1) Represents 173,899 shares held by Thomas Pfisterer ("Mr. Pfisterer"). Mr. Pfisterer has transferred all of his direct or indirect interests in HPWH MH AG ("MH") and HPWH TH AG ("HPWH") to Dr. Hans-Peter Wild ("Dr. Wild"), following stepping down as a member of the Board of HPWH. (2) The beneficial ownership percentage is calculated based on 101,811,051 ordinary shares of the Issuer issued and outstanding as of 5/13/25.
SCHEDULE 13G
|
| Item 1. | |
| (a) | Name of issuer:
ADC Therapeutics SA |
| (b) | Address of issuer's principal executive offices:
Biopole, Route de la Corniche 3B, 1066 Epalinges, Switzerland |
| Item 2. | |
| (a) | Name of person filing:
1. HPWH 2. Dr. Hans-Peter Wild 3. Thomas Pfisterer, Collectively, the "Reporting Persons" |
| (b) | Address or principal business office or, if none, residence:
The address of the Reporting Persons are: Neugasse 22, 6300 Zug, Switzerland (HPWH and Dr. Hans-Peter Wild); Suurstoffi 13A, 6343 Rotkreuz, Switzerland (Thomas Pfisterer) |
| (c) | Citizenship:
1. HPWH - Switzerland 2. Dr. Hans-Peter Wild - Switzerland 3. Thomas Pfisterer - Switzerland |
| (d) | Title of class of securities:
Common Shares, par value CHF 0.08 per share |
| (e) | CUSIP No.:
H0036K147 |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
1. HPWH - 8,670,588 2. Dr. Hans-Peter Wild - 9,788,944 3. Thomas Pfisterer - 173,899 |
| (b) | Percent of class:
1. HPWH - 8.52% 2. Dr. Hans-Peter Wild - 9.61% 3. Thomas Pfisterer - 0.17% %
|
| (c) | Number of shares as to which the person has:
|
| (i) Sole power to vote or to direct the vote:
1. HPWH - 8,670,588 2. Dr. Hans-Peter Wild - 9,788,944 3. Thomas Pfisterer - 173,899 | |
| (ii) Shared power to vote or to direct the vote:
1. HPWH - 0 2. Dr. Hans-Peter Wild - 0 3. Thomas Pfisterer - 0 | |
| (iii) Sole power to dispose or to direct the disposition of:
1. HPWH - 8,670,588 2. Dr. Hans-Peter Wild - 9,788,944 3. Thomas Pfisterer - 173,899 | |
| (iv) Shared power to dispose or to direct the disposition of:
1. HPWH - 0 2. Dr. Hans-Peter Wild - 0 3. Thomas Pfisterer - 0 | |
| Item 5. | Ownership of 5 Percent or Less of a Class. |
|
Ownership of 5 percent or less of a class
| |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
Not Applicable
| |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not Applicable
| |
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable
| |
| Item 9. | Notice of Dissolution of Group. |
Not Applicable
|
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
Exhibit Information
|
Exhibit 1 - Joint Filing Agreement |